The choice of anti hypertensive drugs in patients with erectile dysfunction

被引：20

作者：

Khan, MA

Morgan, RJ

Mikhailidis, DP

机构：

[1] UCL Royal Free Univ Coll, Sch Med, Dept Urol, London, England

[2] UCL Royal Free Hampstead NHS Trust, London, England

[3] UCL Royal Free Univ, Coll Med, Dept Clin Biochem, London, England

[4] UCL Royal Free Hampstead NHS Trust, London, England

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 2002年 / 18卷 / 02期

关键词：

doxazosin; losartan; hypertension; erectile dysfunction; angiotensin II; antihypertensives;

D O I：

10.1185/030079902125000426

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

It is well established that hypertension and the more traditional anti-hypertensive drugs are associated with erectile dysfunction (ED). There is evidence showing that two anti hypertensive drugs - doxazosin and losartan - have a positive effect on erectile function. Therefore these drugs may decrease the incidence of ED in patients who need treatment for hypertension. Doxazosin and/or losartan can also be beneficial in patients who develop ED after starting treatment with other anti hypertensive drugs. These options could, in turn, ensure better compliance and blood pressure control. A fall in the overall cost of treatment will also be anticipated if there is a reduced need for drugs prescribed for ED in patients with hypertension.

引用

页码：103 / 107

页数：5

共 35 条

[1] Sexual function in 131 patients with benign prostatic hyperplasia before prostatectomy [J].

Baniel, J ;

Israilov, S ;

Shmueli, J ;

Segenreich, E ;

Livne, PM .

EUROPEAN UROLOGY, 2000, 38 (01) :53-58

[2] Microcirculatory studies in erectile disorders [J].

Belcaro, G ;

Cesarone, MR ;

Nicolaides, AN ;

Vale, J ;

Glass, J ;

Lennox, A .

CURRENT MEDICAL RESEARCH AND OPINION, 2000, 16 :S72-S75

[3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[4] IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].

FELDMAN, HA ;

GOLDSTEIN, I ;

HATZICHRISTOU, DG ;

KRANE, RJ ;

MCKINLAY, JB .

JOURNAL OF UROLOGY, 1994, 151 (01) :54-61

[5]

Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967

[6] HIGH PREVALENCE OF BENIGN PROSTATIC HYPERTROPHY IN THE COMMUNITY [J].

GARRAWAY, WM ;

COLLINS, GN ;

LEE, RJ .

LANCET, 1991, 338 (8765) :469-471

[7] THE MICROARCHITECTURE OF THE INTRACAVERNOSAL SMOOTH-MUSCLE AND THE CAVERNOSAL FIBROUS SKELETON [J].

GOLDSTEIN, AMB ;

PADMANATHAN, H .

JOURNAL OF UROLOGY, 1990, 144 (05) :1144-1146

[8] Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women - Treatment of Mild Hypertension Study (TOMHS) [J].

Grimm, RH ;

Grandits, GA ;

Prineas, RJ ;

McDonald, RH ;

Lewis, CE ;

Flack, JM ;

Yunis, C ;

Svendsen, K ;

Liebson, PR ;

Elmer, PJ ;

Stamler, J .

HYPERTENSION, 1997, 29 (01) :8-14

[9] Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction [J].

Kaplan, SA ;

Reis, RB ;

Kohn, IJ ;

Shabsigh, R ;

Te, AE .

UROLOGY, 1998, 52 (05) :739-743

[10]

Khan M. A., 2000, Current Drug Targets, V1, P247, DOI 10.2174/1389450003349164

← 1 2 3 4 →